Document text
Principal Investigator: Robert Yarchoan
Organization: DIVISION OF BASIC SCIENCES - NCI
Fiscal Year: 2024
Award: $201,039
Funding agency: National Cancer Institute
The SARS2 Mpro is functional as a dimer; however, its ability to form a dimer is affected by various conditions, such as its state of oxidation and its concentration, Moreover, SARS-CoV-2 Mpro contains 12 cysteines, a large number for a protein of this size. We have observed that the protease has a propensity to undergo oxidation at one or more of these cysteines during purification. This may also occur physiologically, as it would be expected to be under oxidative stress in cells infected with the virus. We have found that Mpro is susceptible to glutathionylation under conditions of oxidative stress. We further showed that the predominantly occurred through glutathionylation of cysteine 300, on the dimer interface, and that thios blocks dimerization of MPro and its activity. This may contribute to viral survival by avoiding killing cells under oxidative stress (such as in bats during migration), and may also reduce the toxicity of Mpro during the latter stages of SARS-CoV-2 replication. We are also working to develop inhibitors of SARS-CoV-2 Mpro. In particular, we are exploring nhibitors of dimizeration, especially those that may bind to cysteine 300. This is being dione in collaboratioin with Dr. Brian Peyser and other colleagues in the NCI. In addition, in collaboration with Dr. Mitsuya (HAMB/CCR/NCI), we have developed two inhibitors that bind to the active site of MPro and have potent activity. Of particular interest is tixiocortal pivalate, a prodrug for tixocortol, which binds to the cysteine 300 of SARS-CoV-2 main protease.
Terms: <2019 novel corona virus><2019 novel coronavirus><2019-nCoV><ARDS><Active Sites><Acute Respiratory Distress><Acute Respiratory Distress Syndrome><Adult ARDS><Adult RDS><Adult Respiratory Distress Syndrome><Affect><Anti-viral Agents><Anti-viral Therapy><Antiproteases><Apoplexy><Bats><Binding><Biochemistry><Biological Chemistry><Brain Vascular Accident><CCR><COVID-19><COVID-19 virus><COVID19 virus><CV-19><Cell Body><Cells><Cerebral Stroke><Cerebrovascular Apoplexy><Cerebrovascular Stroke><Cessation of life><Chiroptera><Clotting><CoV-2><CoV2><Coagulation><Coagulation Process><Collaborations><Coronaviridae><Coronavirus><Coronavirus Infectious Disease 2019><Coughing><Cysteine><Da Nang Lung><Death><Dimerization><Disease Outbreaks><Drug Precursors><Endopeptidase Inhibitors><Esteroproteases><Exposure to><Fever><Half-Cystine><L-Cysteine><MERS corona virus><MERS coronavirus><MERS virus><MERS-CoV><MOF syndrome><Middle East Respiratory Syndrome Corona Virus><Middle East Respiratory Syndrome Coronavirus><Middle East Respiratory Syndrome Virus><Middle East Respiratory Syndrome-CoV><Middle East Respiratory Virus><Middle East Respiratory coronavirus><Middle Eastern Respiratory Syndrome Corona virus><Middle Eastern Respiratory Syndrome Coronavirus><Middle Eastern Respiratory Syndrome Virus><Middle Eastern Respiratory Syndrome-CoV><Molecular Interaction><Multiple Organ Dysfunction Syndrome><Multiple Organ Failure><Non-structural Protein><Nonstructural Protein><Outbreaks><Oxidative Stress><Papain><Peptidase Inhibitors><Peptidases><Peptide Hydrolase Inhibitors><Peptide Hydrolases><Peptide Peptidohydrolase Inhibitors><Physiologic><Physiological><Polyproteins><Predisposition><Pro-Drugs><Prodrugs><Protease Antagonists><Protease Gene><Protease Inhibitor><Proteases><Protein Dimerization><Proteinase Inhibitors><Proteinases><Proteins><Proteolytic Enzymes><Pyrexia><RNA Viruses><SARS><SARS Coronavirus 2 Protease><SARS Virus><SARS corona virus><SARS corona virus 2><SARS coronavirus><SARS coronavirus disease><SARS-Associated Coronavirus><SARS-CO-V2><SARS-COVID-2><SARS-CoV><SARS-CoV disease><SARS-CoV-1><SARS-CoV-2><SARS-CoV-2 inhibitor><SARS-CoV-2 protease><SARS-CoV2><SARS-Related Coronavirus><SARS-associated corona virus 2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-related corona virus 2><SARS-related coronavirus 2><SARSCoV2><Severe Acute Respiratory Coronavirus><Severe Acute Respiratory Coronavirus 2><Severe Acute Respiratory Distress Syndrome CoV 2><Severe Acute Respiratory Distress Syndrome Corona Virus 2><Severe Acute Respiratory Distress Syndrome Coronavirus 2><Severe Acute Respiratory Syndrome><Severe Acute Respiratory Syndrome CoV 2><Severe Acute Respiratory Syndrome CoV disease><Severe Acute Respiratory Syndrome Virus><Severe Acute Respiratory Syndrome corona virus><Severe Acute Respiratory Syndrome coronavirus><Severe Acute Respiratory Syndrome coronavirus disease><Severe Acute Respiratory Syndrome-associated coronavirus 2><Severe Acute Respiratory Syndrome-related coronavirus 2><Severe acute respiratory syndrome associated corona virus 2><Severe acute respiratory syndrome coronavirus 2><Severe acute respiratory syndrome coronavirus 2 inhibitor><Severe acute respiratory syndrome related corona virus 2><Shock Lung><Stiff lung><Stress><Stroke><Structure><Susceptibility><Toxic effect><Toxicities><Viral><Virus><Wuhan coronavirus><anti-viral compound><anti-viral development><anti-viral drug development><anti-viral drugs><anti-viral medication><anti-viral therapeutic><anti-viral therapeutic development><anti-viral therapy development><anti-virals><antiviral development><antiviral drug development><antiviral therapeutic development><antiviral therapy development><block SARS-CoV-2><block severe acute respiratory syndrome coronavirus 2><brain attack><cell killing><cerebral vascular accident><cerebrovascular accident><corona virus><coronavirus disease 2019><coronavirus disease 2019 virus><coronavirus disease-19><coronavirus disease-19 virus><coronavirus infectious disease-19><developing anti-viral agent><developing anti-viral drug><developing anti-viral therapeutic><developing anti-viral therapy><developing antiviral agent><developing antiviral drug><developing antiviral therapeutic><developing antiviral therapy><dimer><febrile><febris><hCoV19><inhibit SARS-CoV-2><inhibit severe acute respiratory syndrome coronavirus 2><inhibitor><interest><migration><multiorgan failure><multiple organ system failure><nCoV2><oxidation><pandemic><pandemic disease><severe acute respiratory syndrome coronavirus 2 protease><severe acute respiratory syndrome-CoV><stroked><strokes><viral infectious disease treatment><wet lung>